Wiley Bros.-aintree Capital »

Fibrobiologics shares owned by Wiley Bros.-aintree Capital

Quarter-by-quarter ownership of Fibrobiologics (FBLG) shares owned by Wiley Bros.-aintree Capital from 13F filings

Historical chart of Wiley Bros.-aintree Capital investment in Fibrobiologics

Tip: Access up to 7 years of quarterly data

All positions including Fibrobiologics held by Wiley Bros.-aintree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrobiologics by Wiley Bros.-aintree Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $55k 100k 0.55
2025-06-30 $44k 70k 0.62

More positions owned by Wiley Bros.-aintree Capital

Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Mcp Etf (IJH)
NVIDIA Corporation (NVDA)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Ishares Tr Core Msci Eafe (IEFA)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Ishares Tr Msci Usa Qlt Fct (QUAL)

View all positions for Wiley Bros.-aintree Capital

Top funds holding Fibrobiologics

Vanguard Group
Yorkville Advisors Global
Millennium Management
BlackRock
Landscape Capital Management
Gts Securities
Cascade Financial Partners
Geode Capital Management
Citadel Advisors
HPM Partners
State Street Corporation
Optivise Advisory Services
Requisite Capital Management
Wiley Bros.-aintree Capital
American Institute for Advanced Investment Management

View all funds holding Fibrobiologics